| 68311-0 |
I was able to dry my back with a towel in the past 7D |
Find |
^Patient |
7D |
Ord |
NeuroQol.Peds |
|
ACTIVE |
I was able to dry my back with a towel in the past 7 days [NeuroQol.Peds] |
|
MAJ |
DefinitionDescription |
|
|
|
|
Copyright �© 2010 David Cella, PhD. Used with permission. All of these Neuro-QOL instruments can be used at no charge. We do ask, however, that you contact Neuro-QOL project manager, Vitali Ustsinovich, at v-ustsinovich@northwestern.edu and let him know that you intend to use Neuro-QOL. |
|
|
|
|
SURVEY.NEUROQ |
|
68311-0 |
|
NeuroQol.Peds |
|
|
|
|
|
|
0 |
|
|
NQUEXped38 |
In the past 7 days I was able to dry my back with a towel. |
N |
|
Finding; Findings; Last; Ordinal; Past 7D able to dry back with towel; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NEUROQ |
2.54 |
2.38 |
|
|
|
|
Copyright �© 2010 David Cella, PhD. Used with permission. All of these Neuro-QOL instruments can be used at no charge. We do ask, however, that you contact Neuro-QOL project manager, Vitali Ustsinovich, at v-ustsinovich@northwestern.edu and let him know that you intend to use Neuro-QOL. |
|
|
|
|
|
|
0 |
| 68312-8 |
I was able to put on my clothes by myself in the past 7D |
Find |
^Patient |
7D |
Ord |
NeuroQol.Peds |
|
ACTIVE |
I was able to put on my clothes by myself in the past 7 days [NeuroQol.Peds] |
|
MAJ |
DefinitionDescription |
|
|
|
|
Copyright �© 2010 David Cella, PhD. Used with permission. All of these Neuro-QOL instruments can be used at no charge. We do ask, however, that you contact Neuro-QOL project manager, Vitali Ustsinovich, at v-ustsinovich@northwestern.edu and let him know that you intend to use Neuro-QOL. |
|
|
|
|
SURVEY.NEUROQ |
|
68312-8 |
|
NeuroQol.Peds |
|
|
|
|
|
|
0 |
|
|
NQUEXped40 |
In the past 7 days I was able to put on my clothes by myself. |
N |
|
Finding; Findings; Last; Ordinal; Past 7D able to put on my clothes; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NEUROQ |
2.54 |
2.38 |
|
|
|
|
Copyright �© 2010 David Cella, PhD. Used with permission. All of these Neuro-QOL instruments can be used at no charge. We do ask, however, that you contact Neuro-QOL project manager, Vitali Ustsinovich, at v-ustsinovich@northwestern.edu and let him know that you intend to use Neuro-QOL. |
|
|
|
|
|
|
0 |
| 68313-6 |
I was able to zip up my clothes in the past 7D |
Find |
^Patient |
7D |
Ord |
NeuroQol.Peds |
|
ACTIVE |
I was able to zip up my clothes in the past 7 days [NeuroQol.Peds] |
|
MAJ |
DefinitionDescription |
|
|
|
|
Copyright �© 2010 David Cella, PhD. Used with permission. All of these Neuro-QOL instruments can be used at no charge. We do ask, however, that you contact Neuro-QOL project manager, Vitali Ustsinovich, at v-ustsinovich@northwestern.edu and let him know that you intend to use Neuro-QOL. |
|
|
|
|
SURVEY.NEUROQ |
|
68313-6 |
|
NeuroQol.Peds |
|
|
|
|
|
|
0 |
|
|
NQUEXped41 |
In the past 7 days I was able to zip up my clothes. |
N |
|
Finding; Findings; Last; Ordinal; Past 7D able to zip up my clothes; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NEUROQ |
2.54 |
2.38 |
|
|
|
|
Copyright �© 2010 David Cella, PhD. Used with permission. All of these Neuro-QOL instruments can be used at no charge. We do ask, however, that you contact Neuro-QOL project manager, Vitali Ustsinovich, at v-ustsinovich@northwestern.edu and let him know that you intend to use Neuro-QOL. |
|
|
|
|
|
|
0 |
| 68314-4 |
Meperidine & Normeperidine panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Meperidine and Normeperidine panel - Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
68314-4 |
|
|
|
|
Order |
|
|
|
0 |
Meperidine + Normeperidine Pnl SerPl |
|
|
|
N |
|
Algil; Alodan; Centralgine; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Meperidine + Normeperidine Pnl; Meperidine metabolite; Meperidine+Nor; Norpethidine; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pethidine; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
2.38 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 68315-1 |
Transcortin & Cortisol.free panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Transcortin and Cortisol.free panel - Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
68315-1 |
|
|
|
|
Order |
|
|
|
0 |
Transcortin+Cortis F pnl SerPl |
|
|
|
N |
|
17-Hydroxycorticosterone; CBG; Chemistry; Compound F; Coritsol; Cort; Corticosteroid binding globulin; Cortis F; Cortisol binding globulin; Cortisol Free Pnl; F; FR; hydrocortisone; Non-protein bound; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Transcortin+Cortis F pnl; UFC |
2.42 |
2.38 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 68317-7 |
Metanephrine, Normetanephrine & Creatinine panel |
- |
Urine |
Pt |
- |
|
|
ACTIVE |
Metanephrine, Normetanephrine and Creatinine panel - Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
68317-7 |
|
|
|
|
Order |
|
|
|
0 |
Metanephs+Creat pnl Ur |
|
|
|
N |
|
CR; Crea; Creat; Creat Pnl; DRUG/TOXICOLOGY; Drugs; Metaneph; Metaneph+Normetaneph; Metanephrine fractionated; Metanephrines panel; Metanephrne; Metanephs+Creat pnl; Metenephrine; Normeta; Normetaneph; Normetanephrn; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UCr; UR; Urn |
2.73 |
2.38 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 68318-5 |
Hypoglycemics panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Hypoglycemics panel - Serum or Plasma |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
68318-5 |
|
|
|
|
Order |
|
|
|
0 |
Hypoglycemics pnl SerPl |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Hypoglycemic Panel; Hypoglycemics pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.38 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 6832-0 |
Fraxinus latifolia Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Oregon Ash IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
6832-0 |
|
|
|
|
Both |
|
|
|
0 |
Oregon Ash IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Oregon ash; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.42 |
1.0h(2) |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
| 68320-1 |
Polio virus Ab panel |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Polio virus Ab panel [Titer] - Serum |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
68320-1 |
|
|
|
|
Order |
|
|
|
0 |
PV Ab Pnl Titr Ser |
|
|
|
N |
|
Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Poliovirus; PV; PV Ab Pnl; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.38 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 68321-9 |
I worried about dying in the past 7D |
Find |
^Patient |
7D |
Ord |
NeuroQol |
|
ACTIVE |
I worried about dying in the past 7 days [NeuroQol] |
|
MAJ |
DefinitionDescription |
|
|
|
|
Copyright �© 2010 David Cella, PhD. Used with permission. All of these Neuro-QOL instruments can be used at no charge. We do ask, however, that you contact Neuro-QOL project manager, Vitali Ustsinovich, at v-ustsinovich@northwestern.edu and let him know that you intend to use Neuro-QOL. |
|
|
|
|
SURVEY.NEUROQ |
|
68321-9 |
|
NeuroQol |
|
|
|
|
|
|
0 |
|
|
NQANX18 |
In the past 7 days I worried about dying. |
N |
|
Finding; Findings; Last; Ordinal; Past 7D worried about dying; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NEUROQ |
2.54 |
2.38 |
|
|
|
|
Copyright �© 2010 David Cella, PhD. Used with permission. All of these Neuro-QOL instruments can be used at no charge. We do ask, however, that you contact Neuro-QOL project manager, Vitali Ustsinovich, at v-ustsinovich@northwestern.edu and let him know that you intend to use Neuro-QOL. |
|
|
|
|
|
|
0 |
| 68322-7 |
I had a lot of pain in the past 7D |
Find |
^Patient |
7D |
Ord |
NeuroQol.Peds |
|
ACTIVE |
I had a lot of pain in the past 7 days [NeuroQol.Peds] |
|
MAJ |
DefinitionDescription |
|
|
|
|
Copyright �© 2010 David Cella, PhD. Used with permission. All of these Neuro-QOL instruments can be used at no charge. We do ask, however, that you contact Neuro-QOL project manager, Vitali Ustsinovich, at v-ustsinovich@northwestern.edu and let him know that you intend to use Neuro-QOL. |
|
|
|
|
SURVEY.NEUROQ |
|
68322-7 |
|
NeuroQol.Peds |
|
|
|
|
|
|
0 |
|
|
NQPAIped01 |
In the past 7 days I had a lot of pain |
N |
|
Finding; Findings; Last; Ordinal; Past 7D lot of pain; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NEUROQ |
2.54 |
2.38 |
|
|
|
|
Copyright �© 2010 David Cella, PhD. Used with permission. All of these Neuro-QOL instruments can be used at no charge. We do ask, however, that you contact Neuro-QOL project manager, Vitali Ustsinovich, at v-ustsinovich@northwestern.edu and let him know that you intend to use Neuro-QOL. |
|
|
|
|
|
|
0 |
| 68323-5 |
My pain was so bad that I needed to take medicine for it in the past 7D |
Find |
^Patient |
7D |
Ord |
NeuroQol.Peds |
|
ACTIVE |
My pain was so bad that I needed to take medicine for it in the past 7 days [NeuroQol.Peds] |
|
MAJ |
DefinitionDescription |
|
|
|
|
Copyright �© 2010 David Cella, PhD. Used with permission. All of these Neuro-QOL instruments can be used at no charge. We do ask, however, that you contact Neuro-QOL project manager, Vitali Ustsinovich, at v-ustsinovich@northwestern.edu and let him know that you intend to use Neuro-QOL. |
|
|
|
|
SURVEY.NEUROQ |
|
68323-5 |
|
NeuroQol.Peds |
|
|
|
|
|
|
0 |
|
|
NQPAIped02 |
In the past 7 days my pain was so bad that I needed to take medicine for it |
N |
|
Finding; Findings; Last; Ordinal; Past 7D needed medicine for pain; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NEUROQ |
2.54 |
2.38 |
|
|
|
|
Copyright �© 2010 David Cella, PhD. Used with permission. All of these Neuro-QOL instruments can be used at no charge. We do ask, however, that you contact Neuro-QOL project manager, Vitali Ustsinovich, at v-ustsinovich@northwestern.edu and let him know that you intend to use Neuro-QOL. |
|
|
|
|
|
|
0 |
| 68324-3 |
von Willebrand factor.activity actual/Normal |
RelRto |
PPP |
Pt |
Qn |
IA |
|
ACTIVE |
von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
COAG |
|
68324-3 |
|
IA |
|
|
Both |
|
|
|
0 |
vWf:Ac Act/Nor PPP IA |
|
|
|
N |
|
Act/Nor; Activ; Actvty; COAGULATION; Control; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; Hematology; Heme; IAA; MEIA; Movements; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; SUDS; Von will; Vonwillebrand; vWf; vWf:Ac |
2.73 |
2.38 |
|
|
|
|
|
|
|
% |
|
|
Renamed Method from "Imm" to "IA" for consistency across classes (approved by Laboratory LOINC Committee 2016 12). |
0 |
| 68325-0 |
Coagulation thrombin induced actual/Normal |
RelTime |
PPP |
Pt |
Qn |
Coag |
|
ACTIVE |
Thrombin time actual/Normal |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
COAG |
|
68325-0 |
|
Coag |
|
|
Observation |
|
|
|
0 |
Thrombin time/normal |
|
|
|
N |
|
Act/Nor; Clot; Clottable; Coag; Coagulation assay; Control; Hematology; Heme; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; RlTm; TCT; Throm; Thrombin clotting time; Thrombin time; Tilt tube; TT |
2.73 |
2.4 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 68326-8 |
Coagulation reptilase induced actual/Normal |
RelTime |
PPP |
Pt |
Qn |
Coag |
|
ACTIVE |
Reptilase time actual/Normal |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
COAG |
|
68326-8 |
|
Coag |
|
|
Observation |
|
|
|
0 |
Reptilase time/normal |
|
|
|
N |
|
Act/Nor; Atroxin time; Clot; Clottable; Coag; Coagulation assay; Control; Hematology; Heme; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Reptilase time; RlTm; Tilt tube |
2.73 |
2.4 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 68327-6 |
Age |
Time |
^Egg donor |
Pt |
Qn |
|
|
ACTIVE |
Egg donor age |
|
MIN |
DefinitionDescription |
|
|
years |
|
|
|
|
|
|
MISC |
|
68327-6 |
|
|
|
|
Observation |
|
|
|
0 |
Egg donor age |
|
|
|
N |
|
Donr; MISC; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
2.38 |
|
|
|
|
|
|
|
a |
|
|
|
0 |
| 68328-4 |
Previous fetus defect |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Previous fetus defect |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
68328-4 |
|
|
|
|
Observation |
|
|
|
0 |
Prev fetus defect |
|
|
|
N |
|
Chemistry; Finding; Findings; Ordinal; Point in time; Prev; Prev fetus defect; Ql; Qual; Qualitative; Random; Screen |
2.73 |
2.38 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 68329-2 |
Country of origin |
Loc |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Country of origin |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.ESRD |
|
68329-2 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
ESRD; ESRD survey; Location; Nominal; Point in time; Random; Survey |
2.52 |
2.38 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 6833-8 |
Cat dander Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Cat dander IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
6833-8 |
|
|
|
|
Both |
|
|
|
0 |
Cat Dander IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cat epithelium; Cat hair; e1; Feline; Felis domesticus; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
| 68330-0 |
CMS certification number - CCN |
ID |
Dialysis facility |
Pt |
Nom |
|
|
TRIAL |
CMS certification number - CCN Dialysis facility |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.ESRD |
|
68330-0 |
|
|
|
|
|
|
|
|
0 |
|
|
ESRD.RQMT_250 |
Dialysis facility's CMS Certification Number (CCN) where the patient is receiving care |
N |
|
CCN; CMS certification #; Dialy; ESRD; ESRD survey; Ident; Identifier; No; Nominal; Num; Point in time; Random; Survey |
2.4 |
2.38 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 68332-6 |
Donor |
Type |
^Patient |
Pt |
Nom |
|
|
TRIAL |
Donor |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.ESRD |
|
68332-6 |
|
|
|
|
|
|
|
|
0 |
|
|
ESRD.RQMT_268 |
Type of donor |
N |
|
ESRD; ESRD survey; Nominal; Point in time; Random; Survey; Typ |
2.44 |
2.38 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 68333-4 |
Date return to dialysis after failed transplant |
Date |
^Patient |
Pt |
Qn |
|
|
TRIAL |
Date return to dialysis after failed transplant |
|
MIN |
DefinitionDescription |
|
|
MMDDYY |
|
|
|
|
|
|
SURVEY.ESRD |
|
68333-4 |
|
|
|
|
|
|
|
|
0 |
|
|
ESRD.RQMT_269 |
If non-functioning, date of return to regular dialysis |
N |
|
Dialy; ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey |
2.5 |
2.38 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 68334-2 |
Current dialysis treatment site |
Type |
^Patient |
Pt |
Nom |
|
|
TRIAL |
Current dialysis treatment site |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.ESRD |
|
68334-2 |
|
|
|
|
|
|
|
|
0 |
|
|
ESRD.RQMT_270 |
Current dialysis treatment site |
N |
|
Dialy; ESRD; ESRD survey; Nominal; Point in time; Random; Survey; Tx; Typ |
2.44 |
2.38 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 68335-9 |
Self-dialysis training facility name |
ID |
Dialysis facility |
Pt |
Nom |
|
|
TRIAL |
Self-dialysis training facility name Dialysis facility |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.ESRD |
|
68335-9 |
|
|
|
|
|
|
|
|
0 |
|
|
ESRD.RQMT_271 |
|
N |
|
Dialy; ESRD; ESRD survey; Ident; Identifier; Nominal; Point in time; Random; Self-dialysis facility name; Survey |
2.4 |
2.38 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 68336-7 |
Self-dialysis training |
Type |
^Patient |
Pt |
Nom |
|
|
TRIAL |
Self-dialysis training |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.ESRD |
|
68336-7 |
|
|
|
|
|
|
|
|
0 |
|
|
ESRD.RQMT_275 |
Type of training |
N |
|
Dialy; ESRD; ESRD survey; Nominal; Point in time; Random; Survey; Typ |
2.44 |
2.38 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
